Pro- and anti-inflammatory cytokines in steatosis and steatohepatitis (Q43068331)

13 November 2017

Pro- and anti-inflammatory cytokines in steatosis and steatohepatitis (English)

1 reference

13 November 2017

0 references

1 reference

Fabiola Rabelo

1

1 reference

13 November 2017

Claudia P M S Oliveira

2

1 reference

13 November 2017

Joel Faintuch

3

1 reference

13 November 2017

Daniel F C Mazo

4

1 reference

13 November 2017

Vicencia M R Lima

5

1 reference

13 November 2017

Jose Tadeu Stefano

6

1 reference

13 November 2017

Hermes V Barbeiro

7

1 reference

13 November 2017

Francisco G Soriano

8

1 reference

13 November 2017

Venancio A Ferreira Alves

9

1 reference

13 November 2017

Flair J Carrilho

10

1 reference

13 November 2017

language of work or name

1 reference

1 July 2010

1 reference

13 November 2017

1 reference

13 November 2017

20

1 reference

13 November 2017

7

1 reference

13 November 2017

906-912

1 reference

https://scigraph.springernature.com/pub.10.1007/s11695-010-0181-4

13 November 2017

0 references

cites work

Early identification of infectious complications in bariatric surgery by the determination of peritoneal and systemic cytokines.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11695-010-0181-4

Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11695-010-0181-4

Treatment of hypertension in metabolic syndrome subjects with amlodipine and olmesartan-effects on oxidized non-esterified free fatty acids and cytokine production

21 January 2018

1 reference

12 December 2020

Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis

1 reference

12 December 2020

Amelioration of non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice by oral immune regulation towards liver-extracted proteins is associated with elevated intrahepatic NKT lymphocytes and serum IL-10 levels

1 reference

12 December 2020

Expression of cytokine signaling genes in morbidly obese patients with non-alcoholic steatohepatitis and hepatic fibrosis.

1 reference

12 December 2020

Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.

1 reference

12 December 2020

Interferon as a factor in recovery from virus infection.

1 reference

12 December 2020

Relationship between anti-fibrotic effect of Panax notoginseng saponins and serum cytokines in rat hepatic fibrosis.

1 reference

12 December 2020

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

12 December 2020

Basal metabolic rate in morbidly obese patients with non-alcoholic fatty liver disease

1 reference

12 December 2020

Balance between pro and anti-inflammatory cytokines in patients with acute alcoholic hepatitis

1 reference

12 December 2020

A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH).

1 reference

12 December 2020

High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH.

1 reference

12 December 2020

Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients with nonalcoholic steatohepatitis

1 reference

12 December 2020

Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease

1 reference

12 December 2020

A randomized controlled pilot study of Pentoxifylline in patients with non-alcoholic steatohepatitis (NASH).

1 reference

12 December 2020

Plasma adiponectin levels in primary biliary cirrhosis: a novel perspective for link between hypercholesterolemia and protection against atherosclerosis

1 reference

12 December 2020

Adipokines and cytokines in non-alcoholic fatty liver disease

1 reference

12 December 2020

Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis

1 reference

12 December 2020

Interleukin-10 prevents diet-induced insulin resistance by attenuating macrophage and cytokine response in skeletal muscle.

1 reference

12 December 2020

Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis

1 reference

12 December 2020

Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients?

1 reference

12 December 2020

Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis

1 reference

12 December 2020

Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort

1 reference

12 December 2020

Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis

1 reference

12 December 2020

Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression

1 reference

12 December 2020

Cellular and molecular mechanisms of fibrosis

1 reference

12 December 2020

Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management

1 reference

12 December 2020

10.1007/S11695-010-0181-4

Identifiers

DOI

1 reference

Dimensions Publication ID

13 November 2017

0 references

1 reference